• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7.

作者信息

Vickers Andrew J, Lilja Hans, Assel Melissa

机构信息

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Departments of Laboratory Medicine and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Translational Medicine, Lund University, Malmö, Sweden; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

出版信息

Eur Urol. 2019 Mar;75(3):e56. doi: 10.1016/j.eururo.2018.10.003. Epub 2018 Oct 14.

DOI:10.1016/j.eururo.2018.10.003
PMID:30327273
Abstract
摘要

相似文献

1
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7.
Eur Urol. 2019 Mar;75(3):e56. doi: 10.1016/j.eururo.2018.10.003. Epub 2018 Oct 14.
2
Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7.回复：梅利莎·阿塞尔、安德斯·达林、大卫·乌尔默特等人。铅时间与前列腺癌分级之间的关联：来自未接受前列腺特异性抗原筛查的大型人群队列长期随访的分级进展证据。《欧洲泌尿外科杂志》2018年；73卷：961 - 967页。
Eur Urol. 2019 Mar;75(3):e54-e55. doi: 10.1016/j.eururo.2018.10.004. Epub 2018 Oct 12.
3
Reply to John T. Leppert and James D. Brooks' Letter to the Editor re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018;74:146-54.对约翰·T·莱珀特和詹姆斯·D·布鲁克斯致编辑的信的回复，信的主题为：布兰登·A·马哈尔、大卫·D·杨、娜塔莉·Q·王等人的《低前列腺特异性抗原、高级别前列腺癌的临床与基因组特征》。《欧洲泌尿外科杂志》2018年；74卷：第146 - 154页。
Eur Urol. 2018 Nov;74(5):e112-e113. doi: 10.1016/j.eururo.2018.06.043. Epub 2018 Jul 18.
4
Re: Giorgio Gandaglia G, Peter Albers, Per-Anders Abrahamsson, et al. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol 2019;76:142-50.回复：乔治·甘达利亚G、彼得·阿尔伯斯、佩尔-安德斯·亚伯拉罕松等。基于人群的前列腺特异性抗原结构化前列腺癌筛查：2019年欧洲泌尿外科学会立场。《欧洲泌尿外科杂志》2019年；76卷：142 - 150页。
Eur Urol. 2020 Jan;77(1):e30. doi: 10.1016/j.eururo.2019.08.030. Epub 2019 Oct 10.
5
Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?对高桥武史致编辑的信的回复：关于亨德里克·范·波佩尔、莫妮克·J·鲁博尔、克里斯托弗·R·查普尔等人的《前列腺特异性抗原检测作为前列腺癌风险适应性早期检测策略的一部分：欧洲泌尿外科学会2021年立场和建议》。《欧洲泌尿外科杂志》2021年；80卷：703 - 711页：你会对自己进行俄罗斯轮盘赌式的前列腺特异性抗原筛查吗？
Eur Urol. 2022 Jan;81(1):e23-e24. doi: 10.1016/j.eururo.2021.10.004. Epub 2021 Oct 29.
6
Reply to Ilias Giannakodimos' Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68.
Eur Urol. 2024 Jul;86(1):e13. doi: 10.1016/j.eururo.2024.04.014. Epub 2024 Apr 26.
7
Reply to Parham Habibzadeh and Farrokh Habibzadeh's Letter to the Editor re: Eric A. Klein, Arnon Chait, Jason M. Hafron, et al. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report. Eur Urol 2017;72:942-9. The Most Appropriate IsoPSA Cutoff for Diagnosis of Prostate Cancer.回复帕尔哈姆·哈比比扎德和法罗赫·哈比比扎德致编辑的信，内容涉及埃里克·A·克莱因、阿农·查伊特、贾森·M·哈夫隆等人的《单参数、基于结构的IsoPSA检测与基于总前列腺特异性抗原浓度的检测相比，在检测任何前列腺癌和高级别前列腺癌方面显示出更高的诊断准确性：初步报告》。《欧洲泌尿外科杂志》2017年；72卷：942 - 949页。前列腺癌诊断的最合适IsoPSA临界值
Eur Urol. 2017 Dec;72(6):e174. doi: 10.1016/j.eururo.2017.07.020. Epub 2017 Aug 6.
8
Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.对穆斯塔法·Z·特米兹和侯赛因·贝西罗格鲁致编辑的信的回复，信的主题为：乔治·甘达利亚、斯蒂芬·A·布尔简、威廉·P·帕克等人。前列腺癌根治术后前列腺特异性抗原持续升高的男性患者术后放疗的影响：一项长期生存分析。《欧洲泌尿外科杂志》2０１７年；７２卷：９１０ - ９１７页 。
Eur Urol. 2018 May;73(5):e131-e132. doi: 10.1016/j.eururo.2018.01.015. Epub 2018 Feb 1.
9
Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.对艾伦·达尔·普拉、斯特凡·叙皮奥和皮鲁斯·加贾尔致编辑的信的回复，信的主题为：乔治·甘达利亚、斯蒂芬·A·布尔简、威廉·P·帕克等人。前列腺癌根治术后前列腺特异性抗原持续升高的男性患者术后放疗的影响：一项长期生存分析。《欧洲泌尿外科杂志》2017年；72卷：910 - 917页
Eur Urol. 2018 Feb;73(2):e36-e37. doi: 10.1016/j.eururo.2017.08.026. Epub 2017 Sep 8.
10
Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.回复：E. 大卫·克劳福德、佩尔-安德斯·亚伯拉罕松。基于前列腺特异性抗原（PSA）的前列腺癌筛查：与其他癌症筛查测试相比如何？《欧洲泌尿外科杂志》2008年；54卷：262 - 273页
Eur Urol. 2009 May;55(5):e88-9; author reply e90-1. doi: 10.1016/j.eururo.2008.11.036. Epub 2008 Nov 29.